<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CD120AEA-FB8C-4583-B0C3-A460490BE9F3"><gtr:id>CD120AEA-FB8C-4583-B0C3-A460490BE9F3</gtr:id><gtr:firstName>Dimitri</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Kullmann</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B502872D-53F9-42EB-8D1E-45D7522C3D98"><gtr:id>B502872D-53F9-42EB-8D1E-45D7522C3D98</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/002FC006-2518-458A-AB1F-FF4586FFE8D7"><gtr:id>002FC006-2518-458A-AB1F-FF4586FFE8D7</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Hanna</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0200373"><gtr:id>530F122E-FBA8-40EA-8BFC-5C84D8C1C7BA</gtr:id><gtr:title>Molecular mechanisms of monogenic epilepsies and related movement disorders</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0200373</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>397483</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Creation of MRC Centre for Neuromuscular Diseases</gtr:description><gtr:id>9F1264D2-2DEA-43C4-884B-1FD79A8A5805</gtr:id><gtr:impact>Several papers have resulted</gtr:impact><gtr:outcomeId>ArQ6H5QSYeS-1</gtr:outcomeId><gtr:partnerContribution>The MRC Centre for Neuromuscular Diseases has capitalised on the channelopathy research that was sponsored by the grant, and has facilitated interactions across a wide community of researchers across UCL and the University of Newcastle</gtr:partnerContribution><gtr:piContribution>I am on the steering committee and help to co-ordinate the seminar programme and the use of animals. My laboratory offers rotations to students on the PhD programme.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visits</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>DCAC80A7-2F83-4573-8A95-010ED3AF5B10</gtr:id><gtr:impact>Pupils at schools sponsored by the Worshipful Company of Pewterers participated in several Science Days run by one of the researchers funded by the grant.

Repeated invitations, nomination for public engagement awards</gtr:impact><gtr:outcomeId>YXkMszAMfie</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Grant: Centre for Neuromuscular Disease</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>AEAD43E3-66B8-4D8A-B943-C59488FDE9D6</gtr:id><gtr:outcomeId>sJtTQCx6wJH0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>242321</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome trust grant: Virally-delivered shRNA for focal epilepsy</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>914C2B0E-3C2B-4AA8-9AC7-B6B9EBAA9D62</gtr:id><gtr:outcomeId>NwLGVRkD3uE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Action Research training fellowship for TG</gtr:description><gtr:end>2008-07-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:id>03E37FBD-C74A-4A11-AB4A-C3A3F8982F88</gtr:id><gtr:outcomeId>UK1QVGZ23mB0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1008392</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC grant: Lentiviral potassium channel expression to treat focal neocortical epilepsy</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>84CA6883-C4F8-40C3-8D6E-C1F64A8B5FBB</gtr:id><gtr:outcomeId>WXJHmAG4Wiy0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust training fellowship for SR</gtr:description><gtr:end>2009-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>1984F18F-ED52-4B8A-9DBB-6FAC3E8D3092</gtr:id><gtr:outcomeId>Saxgype37yW0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Sequencing analysis is now offered for mutations through the channelopathy service at the National Hospital/UCL Institute of Neurology</gtr:description><gtr:id>7B285C31-A98F-440F-A83A-7B104AB2AC2C</gtr:id><gtr:impact>Improved diagnosis of patients with channelopathies</gtr:impact><gtr:outcomeId>QSM2qkMru9G</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Sequencing DNA analysis for CACNA1A, CLCN1 mutations</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Several cDNAs were generated</gtr:description><gtr:id>05998CD9-0100-4C6E-B062-9623764B5933</gtr:id><gtr:impact>The viral vectors have allowed manipulation of neuronal activity</gtr:impact><gtr:outcomeId>TamUt1Wn9ST</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Clones, viral constructs</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>255DBC29-4976-4151-B6E2-C8401B1254CC</gtr:id><gtr:title>Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86694d88fb2c9bb553f0bfcfc3584548"><gtr:id>86694d88fb2c9bb553f0bfcfc3584548</gtr:id><gtr:otherNames>Graves TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>grtKZ7esupM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>766E5393-B3FD-4103-872A-DDAFBA03BEF1</gtr:id><gtr:title>Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb8609980b875605d79eaad613f6e13b"><gtr:id>eb8609980b875605d79eaad613f6e13b</gtr:id><gtr:otherNames>St?dberg T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56de979b3587f1.57290205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28CA8526-3A58-4BA6-A060-98D99DF9A90E</gtr:id><gtr:title>Genetic neurological channelopathies: molecular genetics and clinical phenotypes.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f804d3e647f618a01cc6307129f5106"><gtr:id>6f804d3e647f618a01cc6307129f5106</gtr:id><gtr:otherNames>Spillane J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56de979ba15253.82581735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>057F1517-519F-4164-B598-B36F0CCD174B</gtr:id><gtr:title>Benign neonatal convulsions and spontaneous network activity in the developing brain: is there a link?</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>ddzdgWyDWV7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F28F9F44-CC9B-475A-BA9C-5CA140FE17E1</gtr:id><gtr:title>Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>ngN9GXNpRo9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BF9CE80-CBED-4D4D-B3B2-774941E74655</gtr:id><gtr:title>Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86694d88fb2c9bb553f0bfcfc3584548"><gtr:id>86694d88fb2c9bb553f0bfcfc3584548</gtr:id><gtr:otherNames>Graves TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>djJ3r9t4Hhj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8490C607-BEE6-4360-8C82-2A985AB18734</gtr:id><gtr:title>Neurological channelopathies: new insights into disease mechanisms and ion channel function.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>NvqQjEBCcxB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>692D77DA-0E60-445B-BEEA-73E0642DB25F</gtr:id><gtr:title>Dysfunction of the Ca(V)2.1 calcium channel in cerebellar ataxias.</gtr:title><gtr:parentPublicationTitle>F1000 biology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-594X</gtr:issn><gtr:outcomeId>i7rzvxHKFUP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C047E65-EF87-43B8-84EC-B2DEC8A2A617</gtr:id><gtr:title>Evaluating first seizures in adults in primary care.</gtr:title><gtr:parentPublicationTitle>The Practitioner</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d395a8a7eab5b4d34040d5f391c1164"><gtr:id>4d395a8a7eab5b4d34040d5f391c1164</gtr:id><gtr:otherNames>Mantoan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0032-6518</gtr:issn><gtr:outcomeId>FtE9FdezDzH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64CF435C-CBF5-4D24-A960-F37FBED89512</gtr:id><gtr:title>Neurological channelopathies.</gtr:title><gtr:parentPublicationTitle>Annual review of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0147-006X</gtr:issn><gtr:outcomeId>Y9N5nx8CiqD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>305E2E96-20AE-4DED-9EB2-ADD95862C0EF</gtr:id><gtr:title>Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study</gtr:title><gtr:parentPublicationTitle>LANCET NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b83e47c95c5c571c5fd5e8695e883b3e"><gtr:id>b83e47c95c5c571c5fd5e8695e883b3e</gtr:id><gtr:otherNames>CAVALLERI, GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5a5c92ba43e2d6.82999667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2D36BD2-57C9-4E58-BD8A-D57D3A5C41C3</gtr:id><gtr:title>Sodium channel mutations and epilepsy: association and causation.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7fccc55a62cf97212e1cfed26905242"><gtr:id>f7fccc55a62cf97212e1cfed26905242</gtr:id><gtr:otherNames>Schorge S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>TRupefXTN38</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47F7C71A-E083-469C-89AE-C0814081E083</gtr:id><gtr:title>Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cc40dfc64d4f648f783ef445045a4ff"><gtr:id>5cc40dfc64d4f648f783ef445045a4ff</gtr:id><gtr:otherNames>Heinzen EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5a5c92b9987725.91149415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DA54054-D3D2-4670-BC7D-A9848D764CFC</gtr:id><gtr:title>Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd004fe7995fd24fab161f71a958a5af"><gtr:id>cd004fe7995fd24fab161f71a958a5af</gtr:id><gtr:otherNames>Gilbert GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>KwQQMQgSSxE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0E4D02B-A9AC-42B3-BA6B-8CFB82922582</gtr:id><gtr:title>The Role of Calcium Channels in Epilepsy.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>56dd6300a2b1c0.92235475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>320FE2F6-D6BC-4643-A041-88059AD7FABD</gtr:id><gtr:title>Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/838e8f2c5bc345579040f53338850cb2"><gtr:id>838e8f2c5bc345579040f53338850cb2</gtr:id><gtr:otherNames>Cavalleri G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>5a5c92ba602bb7.34857057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5DACAB3-6FCB-413D-95A5-A266D82B60FA</gtr:id><gtr:title>Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>bUPxoxeDdin</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB8EB041-D889-4A85-9909-DBC86FB36809</gtr:id><gtr:title>Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86eb63290fdcd11754a77699cac61733"><gtr:id>86eb63290fdcd11754a77699cac61733</gtr:id><gtr:otherNames>Matthews E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>CjRtk8NFCxz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD200596-8AC0-4E41-9691-B24D69E702CA</gtr:id><gtr:title>A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7204e0994584ae87d35d658678945308"><gtr:id>7204e0994584ae87d35d658678945308</gtr:id><gtr:otherNames>Cavalleri GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>5a5c92b9726de1.33078158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FF263A0-ABD1-4F0E-AACB-7809FDA7F2DE</gtr:id><gtr:title>De novo KCNA2 mutations cause hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c013841a89d3.29667641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34446714-81CA-4528-95C8-89D26192740D</gtr:id><gtr:title>Epileptogenesis is associated with enhanced glutamatergic transmission in the perforant path.</gtr:title><gtr:parentPublicationTitle>Journal of neurophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d125671b695fc3cf5aac8307d0ba6e6"><gtr:id>3d125671b695fc3cf5aac8307d0ba6e6</gtr:id><gtr:otherNames>Scimemi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3077</gtr:issn><gtr:outcomeId>Qzk3MMz6sJF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F49194E-ABE1-43BC-B4BA-FDE25D719AC1</gtr:id><gtr:title>Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo.</gtr:title><gtr:parentPublicationTitle>Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1388-2457</gtr:issn><gtr:outcomeId>H3TzkLJpLwK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3B91C70-7014-4BEA-8AF4-1E8253AA2CC5</gtr:id><gtr:title>Kv1.1 channelopathy abolishes presynaptic spike width modulation by subthreshold somatic depolarization.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc1ff082016dd34c0b053ded4582c910"><gtr:id>bc1ff082016dd34c0b053ded4582c910</gtr:id><gtr:otherNames>Vivekananda U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c0141a8170d6.41305098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DF06BEC-981F-4445-BCE4-C52FEDF037CD</gtr:id><gtr:title>Cell death pathways in Parkinson's disease: role of mitochondria.</gtr:title><gtr:parentPublicationTitle>Antioxidants &amp; redox signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/521f8366c59ab87c062c9c49a518c4b8"><gtr:id>521f8366c59ab87c062c9c49a518c4b8</gtr:id><gtr:otherNames>Yao Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1523-0864</gtr:issn><gtr:outcomeId>5a5c92b1122d07.77857385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABC694FF-C73C-403F-9BBE-22AFA129560C</gtr:id><gtr:title>Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ba1bb31dc3adc9eddf6a5a6486279c1"><gtr:id>1ba1bb31dc3adc9eddf6a5a6486279c1</gtr:id><gtr:otherNames>Fialho D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>UQ1hmTitKpZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A94C1233-FB6B-4E62-A691-00E10DCF0336</gtr:id><gtr:title>Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3d700fecb67b99136b863c2ea912693"><gtr:id>d3d700fecb67b99136b863c2ea912693</gtr:id><gtr:otherNames>Labrum RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>XPcuTn98S9C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D77951CD-D6AF-4641-BCC3-A5ADA7B30302</gtr:id><gtr:title>Gene therapy in epilepsy-is it time for clinical trials?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>546238598afdd2.88501117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEF8124F-E4BB-44A4-91E9-5B6CD6ED7282</gtr:id><gtr:title>Genetics of epilepsy: epilepsy research foundation workshop report.</gtr:title><gtr:parentPublicationTitle>Epileptic disorders : international epilepsy journal with videotape</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c68df3b2ba4827cafde3a4c6b3cf0167"><gtr:id>c68df3b2ba4827cafde3a4c6b3cf0167</gtr:id><gtr:otherNames>Sisodiya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1294-9361</gtr:issn><gtr:outcomeId>5a5c92b9d9b2c4.80679453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73CE5183-C945-4B0C-A6CF-A7A6B08650F3</gtr:id><gtr:title>Cortical inhibition, pH and cell excitability in epilepsy: what are optimal targets for antiepileptic interventions?</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1dfdefb4f074acaad26adccba29954d"><gtr:id>b1dfdefb4f074acaad26adccba29954d</gtr:id><gtr:otherNames>Pavlov I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>pm_15917_27_22890709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8F5FB3B-521D-46AC-83E0-7E4AF73E9FBF</gtr:id><gtr:title>Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a20e72a3e8d6bf7bfeb9b85136eacf9d"><gtr:id>a20e72a3e8d6bf7bfeb9b85136eacf9d</gtr:id><gtr:otherNames>Sleiman PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>5a5c92b14da435.94093327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1B50D1F-309B-4483-B432-FC1F59D01C41</gtr:id><gtr:title>PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15917_27_23077024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37D7321B-155C-4819-B878-B1CF39371A9F</gtr:id><gtr:title>In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15917_27_23065794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>563A4594-84DF-4DEA-AB70-0ECD8F1F1EF7</gtr:id><gtr:title>Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d026b6fd7ea5c4fe5699f012641dca5"><gtr:id>5d026b6fd7ea5c4fe5699f012641dca5</gtr:id><gtr:otherNames>Imbrici P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>CbQwhUfrdJ7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FBA798A-4DB2-4628-8EB6-8EF50E130333</gtr:id><gtr:title>Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15917_27_23349320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E0D55C8-8F7A-4C3B-8D57-B2A80BA7453B</gtr:id><gtr:title>Differential DJ-1 gene expression in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a129ffd0554635defe92554b9ccfbb8f"><gtr:id>a129ffd0554635defe92554b9ccfbb8f</gtr:id><gtr:otherNames>Kumaran R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>5a5c92b2034333.19112712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6F84CAA-32CD-4948-8EC5-9DD77E6C6651</gtr:id><gtr:title>Autoimmune synaptopathies.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6837a62e3d7c04b652a506c6ef070db6"><gtr:id>6837a62e3d7c04b652a506c6ef070db6</gtr:id><gtr:otherNames>Crisp SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn><gtr:outcomeId>56de979bcda398.42101723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC89F994-B1AE-4864-B757-0DAD31356F0C</gtr:id><gtr:title>Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic review.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c91f13481ecffef6f93e85f05e3620a"><gtr:id>4c91f13481ecffef6f93e85f05e3620a</gtr:id><gtr:otherNames>Anagnostou ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>585d3990527044.21598463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BFABFD8-4ADA-45FF-87E8-059C58678392</gtr:id><gtr:title>Chemical-genetic attenuation of focal neocortical seizures.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e71c4ba694ccab7ce7b6754c5c8856a6"><gtr:id>e71c4ba694ccab7ce7b6754c5c8856a6</gtr:id><gtr:otherNames>K?tzel D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>54623858f031f2.58887089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FF9CC96-F9D8-41D3-B6C3-63A45A65E84E</gtr:id><gtr:title>Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ba1bb31dc3adc9eddf6a5a6486279c1"><gtr:id>1ba1bb31dc3adc9eddf6a5a6486279c1</gtr:id><gtr:otherNames>Fialho D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>AywzSipZeYt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77AB79E2-C1B6-4757-AD9B-325A8FF10819</gtr:id><gtr:title>A patient with episodic ataxia and paramyotonia congenita due to mutations in KCNA1 and SCN4A.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>QFyHKC5gDzm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8879E852-8B8E-4720-8237-51144EFD6C18</gtr:id><gtr:title>No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.</gtr:title><gtr:parentPublicationTitle>Epilepsy research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39b64d3ef3b2a06841d419dc7fa8db61"><gtr:id>39b64d3ef3b2a06841d419dc7fa8db61</gtr:id><gtr:otherNames>Lynch JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0920-1211</gtr:issn><gtr:outcomeId>5a5c92b5985039.62740206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AC30EC9-D5C1-409B-8380-55912BBC14CE</gtr:id><gtr:title>GABAA receptor mutations in epilepsy (commentary on Lachance-Touchette et al.).</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5ddd5dcaa4de64212db06858b662189"><gtr:id>e5ddd5dcaa4de64212db06858b662189</gtr:id><gtr:otherNames>Reid CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>i8ifLQmiDHv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1ACED29-5B86-4372-B4C7-EF4C5301F81F</gtr:id><gtr:title>Sodium channelopathy of peripheral nerve: tightening the genotype-phenotype relationship.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7fccc55a62cf97212e1cfed26905242"><gtr:id>f7fccc55a62cf97212e1cfed26905242</gtr:id><gtr:otherNames>Schorge S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>KgeV36Q9U5E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38F8FC9E-1BC4-4CAC-B7DF-566819562C40</gtr:id><gtr:title>Episodic ataxia type 1: a neuronal potassium channelopathy.</gtr:title><gtr:parentPublicationTitle>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1878-7479</gtr:issn><gtr:outcomeId>PrbwgN4NPer</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7230A339-D1FD-456C-B85D-7E893473D9F5</gtr:id><gtr:title>In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56de979c022f19.86414357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7F4105B-A5EE-47A8-B08F-02722C8A76F2</gtr:id><gtr:title>The clinical and genetic heterogeneity of paroxysmal dyskinesias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56de9a2dcd6de9.36202092</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01AD6E34-4806-4087-9096-52CFCE7CA1E8</gtr:id><gtr:title>NONGENETIC FACTORS INFLUENCE SEVERITY OF EPISODIC ATAXIA TYPE 1 IN MONOZYGOTIC TWINS</gtr:title><gtr:parentPublicationTitle>NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6436138bf0b09fb013df7c2d82e1148c"><gtr:id>6436138bf0b09fb013df7c2d82e1148c</gtr:id><gtr:otherNames>Graves Tracey D.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5a36097f67d2a4.61280763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>757632F0-CF07-40F9-987B-B606A798548C</gtr:id><gtr:title>Characterization of PLA2G6 as a locus for dystonia-parkinsonism.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7e7ca46dd73dfb1e927975f9d7e0b57"><gtr:id>e7e7ca46dd73dfb1e927975f9d7e0b57</gtr:id><gtr:otherNames>Paisan-Ruiz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>5a5c92b1baac46.47847290</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0200373</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>